Supplemental Material Appendix Supplementary Table 1 Supplementary Table 2 Figure 1 Figure 2. Appendix Box. The SAS code for the simulations

Size: px
Start display at page:

Download "Supplemental Material Appendix Supplementary Table 1 Supplementary Table 2 Figure 1 Figure 2. Appendix Box. The SAS code for the simulations"

Transcription

1 Supplemental Material Appendix Supplementary Table 1 Supplementary Table 2 Figure 1 Figure 2 Appendix Box. The SAS code for the simulations 1. The SAS code for the simulation model with a constant standard deviation (SD) is as following: do i=1 to 1400; kidney_fcn=max(1, 50+15*rannor(0)); igfr=max(1, kidney_fcn+5*rannor(0)); CrCl=max(1, kidney_fcn*1.13+7*rannor(0)); Output ; end ; 2. The SAS code for the simulation model with a constant coefficient of variation (CV) is as following: do i=1 to 1400; 1

2 kidney_fcn=max(1, 50+15*rannor(0)); igfr=max(1, kidney_fcn*( *rannor(0)); CrCl=max(1, kidney_fcn*1.13*( *rannor(0)); Output ; end ; 3. The SAS code for the simulation model with a uniform distribution of true kidney function from 20 to 80 ml/min/1.73m 2 (i.e. instead of bell-shaped distribution, the distribution is rectangle-shaped) is as following: do i=1 to 1400; kidney_fcn=50-sqrt(3)*15+sqrt(12)*15*ranuni(0); igfr=max(1, kidney_fcn+5*rannor(0)); CrCl=max(1, kidney_fcn*1.13+7*rannor(0)); Output ; end ; 2

3 Supplementary Table 1. Quotes from textbooks and review articles regarding enhanced creatinine secretion Reference Content Basis for statement Inker LA, Perrone RD: Assessment of kidney function, In: UpToDate, section editor: Sterns RH, Aug 27, 2014 Inker LA, Perrone RD: Calculation of the creatinine clearance, In: UpToDate, section editor: Sterns RH, Dec 04, 2015 In reality, a reduction in GFR results in increased tubular creatinine secretion that blunts the rise in serum creatinine. As the GFR falls, the rise in the serum creatinine is partially opposed by enhanced proximal tubular creatinine secretion. The increase in creatinine secretion as GFR falls can limit the interpretation of the creatinine clearance. However, tubular secretion by the organic cation secretory pathways in the proximal tubule accounts for approximately 10 to 20 percent of urinary creatinine in patients with a normal GFR and a progressively higher percentage as the GFR falls. However, the increase in creatinine secretion will result in the creatinine Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65-79, 1962 Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease: a reappraisal. Br Med J 4:11-14, 1969 Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: , 1990 Petri M, Bockenstedt L, Colman J, Whiting-O Keefe Q, Fitz G, Sebastian A, Hellmann D: Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 34: , 1988 van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 340: , 1992 Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65-79, 1962 Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease: a reappraisal. Br Med J 4:11-14, 3

4 clearance being a progressively greater overestimate of the GFR Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: , 1990 Petri M, Bockenstedt L, Colman J, Whiting-O Keefe Q, Fitz G, Sebastian A, Hellmann D: Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 34: , 1988 van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 340: , 1992 Israni AK, Kasiske BL: Laboratory assessment of kidney disease: glomerular filtration rate, urinalysis, and proteinuria. In: Brenner & Rector's The kidney, 9th ed., edited by Brenner BM, Philadelphia, Elsevier Saunders, 2011, pp Lafyette RA, Perrone RD, Levey AS: Laboratory Evaluation of Renal Function. In: Diseases of the Kidney, 6th The tendency for tubular secretion to rise proportionally with declining levels of kidney function, for example, decreases the usefulness of creatinine clearance determinations as accurate reflections of GFR in patients with kidney disease. Although the overestimation of GFR by creatinine clearance is not clinically significant in individuals with normal GFR, in patients with renal disease and decreased GFR the overestimation is proportionally greater and is not Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39: ,

5 ed., edited by Schrier RW, Gottschalk CW, Philadelphia, Lippincott Williams & Wilkins, 1996, pp Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39: , 1988 Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: , 1990 predictable. However, because of the increasing contribution of creatinine secretion to creatinine clearance as GFR declines, creatinine clearance might fall minimally or even remain stable despite a decline in GFR. When GFR first declines, tubular secretion is augmented, stabilizing the serum level. Hence, clearance due to tubular secretion rises; consequently, creatinine clearance (Ccr) declines more slowly than GFR, and the ratio of Ccr to GFR rises. Thereafter, as GFR declines further, tubular secretion increases further, but not in proportion to the increase in serum level. Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2: , 1982 Hilton PJ, Roth Z, Lavender S, Jones NF: Creatinine clearance in patients with proteinuria. Lancet 2: , 1969 Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease: a reappraisal. Br Med J 4:11-14, 1969 Modification of Diet in Renal Disease Study Group. Prepared by Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG: Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int 36(suppl 27):S73-S80, 1989 Walser M, Drew HH, LaFrance ND: Creatinine measurements often yield false estimation of progression in chronic renal 5

6 Mandayam S, Mitch WE: Dietary Factors in the treatment of chronic kidney disease. In: Diseases of the Kidney & Urinary Tract, 8th ed., edited by Schrier RW, Philadelphia, Lippincott Williams & Wilkins, 2007, pp Pearlman AM, Gonin JM: Evaluation of Kidney Function: Biochemical and Nuclear Medicine Tests. In: Handbook of Nephrology & Hypertention, 5th ed., edited by Wilcox CS, Tisher CC, Philadelphia, Lippincott Williams & Wilkins, 2004, pp Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: new insights into old concepts. The 24-hour endogenous creatinine clearance usually exceeds inulin clearance, because of tubular secretion of creatinine, but with advanced CKD, values of creatinine clearance and GFR become numerically closer, even through the percentage difference between creatinine clearance and GFR will increase. Tubular secretion of creatinine normally accounts for 10-40% of that excreted, but this percentage increases in those with chronic renal insufficiency disease. Thus, creatinine clearance systematically overestimates the GFR, particularly in chronic renal insufficiency. However, as the GFR falls, the ratio of creatinine to inulin clearance increases because of an increased tubular secretion of creatinine. failure. Kidney Int 43: , 1988 Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2: , 1982 Lubowitz H, Slatopolsky E, Shankel S, et al: Glomerular filtration rate: determination in patients with chronic renal disease. JAMA 199: , 1967 Mitch WE: Measuring the rate of progression of renal insufficiency. The Progressive Nature of Renal Disease. New York: Churchill Livingston, 1992, pp 203 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:S1, 2002 Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2: ,

7 Clin Chem 38: , 1992 Bennett WM, Porter GA: Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J 4:84-86, 1971 Dodge WF, Travis LB, Daeschner CW: Comparison of endogenous creatinine clearance with inulin clearance. Am J Dis Child 113: , 1967 Hilton PJ, Roth Z, Lavender S, Jones NF: Creatinine clearance in patients with proteinuria. Lancet 2: , 1969 Kassirer JP: Clinical evaluation of kidney function-glomerular function. N Engl J Med 285: , 1971 Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease. A reappraisal. Br Med J 4:11-14, 1969 Lavender S, Hilton PJ, Jones NF: The measurment of glomerular filtration rate in renal disease. Lancet 2: , 1969 Miller BF, Winkler AW: The renal excretion of endogenous creatinine in man. Comparison with exogenous creatinine and inulin. J Clin Invest 17:31-40, 1938 Shannon J: The renal excretion of creatinine in man. J Clin Invest 14: ,

8 Reiser IW, Porush JG: Evaluation of Renal Function. In: Massry & Glassock s Textbook of nephrology, 3rd ed., edited by Massry SG, Glassock RJ, Baltimore Williams & Wilkins, 1995, pp Schwartz GJ, Furth SL: Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 22: , 2007 Shoskes DA, McMahon AW: Renal Physiology and Pathophysiology. In: Campbell-Walsh Urology, 10th ed., edited by Kavoussi LR, Partin AW, Novick AC, Peters CA, Philadelphia, Elsevier Saunders, 2012, pp Toto RD: Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr With renal failure, however, this fortuitous relationship no longer exists because tubular secretion of creatinine assumes a greater percentage of the excreted load and the percentage error reflected by the noncreatinine chromogens diminishes as the serum creatinine increases. Whereas urinary creatinine contributed by tubular secretion does not normally exceed 10%, this fraction rises greatly during chronic renal insufficiency, and creatinine clearance may greatly exceed GFR, particularly at low levels of GFR. As GFR falls, tubular secretion of creatinine increases; so, plasma creatinine may not change noticeably until there has been a significant drop in GFR. Creatinine clearance overestimates true GFR, on average, by 10% to 20%. This becomes even more important as GFR declines, because tubular secretion increases in response to increasing serum creatinine levels and may contribute up to 35% of all creatinine removal at GFR levels of 40-80ml/min. In patients with renal insufficiency the fractional secretion of creatinine increases substantially; therefore, the error in overestimating GFR increases as fractional creatinine secretion increases. Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2: , 1982 Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: , 1990 Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39: , 1988 Arant BS Jr, Edelmann CM Jr, Spitzer A. The congruence of creatinine and inulin clearances in children: Use of the Thchnicon autoanalyzer. J Pediatr 81: , 1972 Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65-79, 1962 Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD, and the Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic 8

9 Opin Nephrol Hypertens 4: ; discussion , 1995 Walser M: Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 32:23-31, 1998 The ratio of creatinine clearance (Ccr) to simultaneously determined GFR (Ccr/GFR) is almost always greater than unity and increases with decreasing GFR to a maximum average of approximately 1.7 at a GFR of approximately 20ml/min. nephropathy. Am J Kidney Dis 16: , 1990 Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2: , 1982 Bennett WM, Porter GA: Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J 4:84-86, 1971 Brown SC, O Reilly PH: Glomerular filtraiton rate measurment: A neglected test in urological practice. Br J Urol 75: , 1995 Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65-79, 1962 Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease. A reappraisal. Br Med J 4:11-14, 1969 Lavender S, Hilton PJ, Jones NF: The measurment of glomerular filtration rate in renal disease. Lancet 2: , 1969 Luke DR, Halstenson CE, Opsahl JA, Matzke GR: Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther 48: ,

10 Van Lente F, Suit P: Assessment of renal function by serum creatinine and creatinine clearance: Glomerular filtration rate estimated by four procedures. Clin Chem 35: ,

11 Supplementary Table 2. Baseline characteristics of the study population Characteristic N=1342 Age (years) 56.2 ± 12.2 Male gender, % 56.7% Race/Ethnicity, % Non-Hispanic white 42.3% Non-Hispanic black 36.8% Hispanic 14.0% Others 6.9% Creatinine clearance (CrCl) (ml/min/1.73m 2 ) 52.1 ± 25.8 Iothalamate measured glomerular filtration rate (igfr) 48.0 ± 19.9 (ml/min/1.73m 2 ) CrCl/iGFR, mean ± SD 1.13 ± 0.46 CrCl/iGFR, median (IOR) 1.09 (0.88, 1.32) Physical examinations Body mass index (kg/m 2 ) 31.3 ± 6.8 Body surface area (m 2 ) 2.0 ± 0.3 Systolic blood pressure (mmhg) 129 ± 22 Diastolic blood pressure (mmhg) 73 ± 13 Self-reported comorbidities, % Diabetes, % 48.3% Cardiovascular disease, % 26.4% Peripheral vascular disease, % 5.7% Stroke, % 8.0% Current smoking, % 11.2% Laboratory results Serum creatinine (mg/dl) 1.70 ± 0.56 BUN (mg/dl) 29 ± 13 Albumin (g/dl) 3.9 ± 0.5 Hematocrit (%) 37.4 ± 4.9 Triglyceride (mg/dl) 155 ± 112 LDL cholesterol (mg/dl) 103 ± 36 Fasting glucose (mg/dl) 113 ± 49 Hemoglobin A1C (%) 6.6 ± 1.6 hs-crp (mg/l) [median (IQR)] 2.2 ( ) 24-hrs urine albumin (mg/24 hrs) [median (IQR)] 84 (11-643) 11

12 Supplementary Figure 1. A. B. (A) Relationship between CrCl/iGFR ratio and igfr, (B) Relationship between CrCl/iGFR ratio and CrCl (The line shown through the scatterplot is from LOESS) 12

13 Supplementary Figure 2. Mean=1.13 Relationship between CrCl/iGFR ratio and mean of CrCl and igfr (The line shown is from LOESS) 13

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children *H W Dilanthi 1, G A M Kularatnam 1, S Jayasena 1, E Jasinge 1, D B D L Samaranayake

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure

More information

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National

More information

Diabetologia 9 Springer-Verlag 1994

Diabetologia 9 Springer-Verlag 1994 Diabetologia (1994) 37:708-712 Diabetologia 9 Springer-Verlag 1994 Monitoring kidney function in diabetic nephropathy P. Rossing, A.-S. Astrup, U. M. Smidt, H.-H. Parving Steno Diabetes Center, Gentofte,

More information

Renal Clearance. Dr. Eman El Eter

Renal Clearance. Dr. Eman El Eter Renal Clearance Dr. Eman El Eter Concept of clearance Clearance is the volume of plasma that is completely cleared of a substance each minute. Example: Renal clearance of Substance X is defined as the

More information

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Ιατρική Σχολή ΑΠΘ Νοσοκομείο ΑΧΕΠA Θεσσαλομίκη Kidney in body homeostasis Excretory function Uremic toxins removal Vascular volume maintainance Fluid-electrolyte

More information

Assessing Renal Function: What you Didn t Know You Didn t Know

Assessing Renal Function: What you Didn t Know You Didn t Know Assessing Renal Function: What you Didn t Know You Didn t Know Presented By Tom Wadsworth PharmD, BCPS Associate Clinical Professor UAA/ISU Doctor of Pharmacy Program Idaho State University College of

More information

BCH472 [Practical] 1

BCH472 [Practical] 1 BCH472 [Practical] 1 1. They function as filters, removing metabolic products and toxins from the blood and excreting them through the urine. 2. They regulate the body s fluid status, electrolyte balance,

More information

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Renal Physiology April, 2011 J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Office : Room 105, Physiology Unit. References: Koeppen B.E. & Stanton B.A. (2010).

More information

ACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD )

ACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD ) 005 16 175-180 1 1 ( chronic kidney disease, CKD ) 003 ( end-stage renal disease, ESRD ) Angiotensin-converting enzyme inhibitors ( ) angiotensin receptor blockers ( ) nondihydropyridine ( NDHP ) / NDHP

More information

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid Archives of Disease in Childhood, 1972, 47, 613. Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid C. CHANTLER* and T. M. BARRATT From the Department of Immunology,

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Special Challenges and Co-Morbidities

Special Challenges and Co-Morbidities Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine

More information

The Seventh Report of the Joint National Commission

The Seventh Report of the Joint National Commission The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study Mark J. Sarnak, MD; Tom Greene, PhD; Xuelei Wang,

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

BIOL 2402 Renal Function

BIOL 2402 Renal Function BIOL 2402 Renal Function Dr. Chris Doumen Collin County Community College 1 Renal Clearance and GFR Refers to the volume of blood plasma from which a component is completely removed in one minute by all

More information

Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study

Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study Lin et al. BMC Nephrology 2013, 14:268 RESEARCH ARTICLE Open Access Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional

More information

Lecture-2 Review of the previous lecture:

Lecture-2 Review of the previous lecture: Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

Kidney Disease. Chronic kidney disease (CKD) requiring dialysis. The F.P. s Role in the Management of Chronic. Stages

Kidney Disease. Chronic kidney disease (CKD) requiring dialysis. The F.P. s Role in the Management of Chronic. Stages Focus on CME at McMaster University The F.P. s Role in the Management of Chronic Kidney Disease By David N. Churchill, MD, FRCPC, FACP Presented at McMaster University CME Half-Day in Nephrology for Family

More information

HHS Public Access Author manuscript Am J Kidney Dis. Author manuscript; available in PMC 2017 July 05.

HHS Public Access Author manuscript Am J Kidney Dis. Author manuscript; available in PMC 2017 July 05. HHS Public Access Author manuscript Published in final edited form as: Am J Kidney Dis. 2017 March ; 69(3): 482 484. doi:10.1053/j.ajkd.2016.10.021. Performance of the Chronic Kidney Disease Epidemiology

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests Renal Tests Holly Kramer MD MPH Associate Professor of Public Health Sciences and Medicine Division of Nephrology and Hypertension Loyola University of Chicago Stritch School of Medicine Renal Tests 1.

More information

Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease

Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Kidney Diseases Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Osama El Minshawy, 1 Eman El-Bassuoni 2 Original Paper 1 Department

More information

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients? Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration

More information

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention And Treatment of Diabetic Nephropathy MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention Tight glucose control reduces the development of diabetic nephropathy Progression

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

BASELINE CHARACTERISTICS OF THE STUDY POPULATION COMPARISON OF TREATING METABOLIC ACIDOSIS IN CKD STAGE 4 HYPERTENSIVE KIDNEY DISEASE WITH FRUITS & VEGETABLES OR SODIUM BICARBONATE This was a 1-year, single-center, prospective, randomized, interventional

More information

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;inpress Published online in press HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE

More information

(renoprotective (end-stage renal disease, ESRD) therapies) (JAMA)

(renoprotective (end-stage renal disease, ESRD) therapies) (JAMA) [1], 1., 2. 3. (renoprotective (end-stage renal disease, ESRD) therapies) (JAMA) (multiple risk (renal replacement therapy, RRT) factors intervention treatment MRFIT) [2] ( 1) % (ESRD) ( ) ( 1) 2001 (120

More information

Journal of Medical Science & Technology

Journal of Medical Science & Technology Journal of Medical Science & Technology Original research Reference Intervals For Serum Creatinine In Nepal. Open Access Sushil Kumar 1, Roshan Takhelmayum 2, Athokpam Rajendra Singh 3, Jitendra Narayan

More information

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program

More information

Introduction to Clinical Diagnosis Nephrology

Introduction to Clinical Diagnosis Nephrology Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College

More information

Comparison between the efficacy of double blockade and single blockade of RAAS in diabetic kidney disease

Comparison between the efficacy of double blockade and single blockade of RAAS in diabetic kidney disease International Journal of Advances in Medicine Gupta A et al. Int J Adv Med. 2018 Aug;5(4):931-935 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20183122

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic

More information

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure. Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test

More information

www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to

More information

Long-term outcomes in nondiabetic chronic kidney disease

Long-term outcomes in nondiabetic chronic kidney disease original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease

More information

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening

More information

9. GFR - WHERE ARE WE NOW?

9. GFR - WHERE ARE WE NOW? How to Cite this article: GFR Where are We Now? - ejifcc 20/01 2009 http://www.ifcc.org 9. GFR - WHERE ARE WE NOW? Joris R. Delanghe 9.1 Abstract The availability of a worldwide standard for creatinine

More information

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA

More information

SAMPLE. Overview: Pathophysiology of the Kidney. Janelle Gonyea, RD, LD, and Maureen McCarthy, MPH, RD, CSR, LD

SAMPLE. Overview: Pathophysiology of the Kidney. Janelle Gonyea, RD, LD, and Maureen McCarthy, MPH, RD, CSR, LD 1 Overview: Pathophysiology of the Kidney Janelle Gonyea, RD, LD, and Maureen McCarthy, MPH, RD, CSR, LD Basic Kidney Structure and Function The kidneys are located symmetrically on either side of the

More information

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Janice P. Lea, MD, MSc, FASN Professor of Medicine Chief Medical Director of Emory Dialysis ASH Clinical Specialist

More information

You should know the T max for any substance that you use and for PAH ; T max = mg / min

You should know the T max for any substance that you use and for PAH ; T max = mg / min Tubular function - What is clearance? o clearance referred to the theoretical volume of plasma from which a substance is cleared ( cleaned ) over a period of time and so its unit would be ((ml/min)) -

More information

Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients

Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients Diabetes Care Publish Ahead of Print, published online May 12, 2009 Albuminuria and GFR Decline in Diabetes Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in

More information

Renal Protection Staying on Target

Renal Protection Staying on Target Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary

More information

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1 Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance BCH472 [Practical] 1 -Kidney functions: - The kidneys serve three essential functions: 1. They function as filters, removing metabolic

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen

More information

Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease

Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular

More information

Chronic Kidney Disease: Optimal and Coordinated Management

Chronic Kidney Disease: Optimal and Coordinated Management Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,

More information

Case Studies: Renal and Urologic Impairments Workshop

Case Studies: Renal and Urologic Impairments Workshop Case Studies: Renal and Urologic Impairments Workshop Justine Lee, MD, DBIM New York Life Insurance Co. Gina Guzman, MD, DBIM, FALU, ALMI Munich Re AAIM Triennial October, 2012 The Company You Keep 1 Case

More information

Solving Slowing Progressive Renal Disease

Solving Slowing Progressive Renal Disease Focus on CME at Memorial University of Newfoundland Solving Slowing Progressive Risk factors and treatment strategies for patients with kidney and cardiovascular disease overlap. Thus, evaluating renal

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Classification of CKD by Diagnosis

Classification of CKD by Diagnosis Classification of CKD by Diagnosis Diabetic Kidney Disease Glomerular diseases (autoimmune diseases, systemic infections, drugs, neoplasia) Vascular diseases (renal artery disease, hypertension, microangiopathy)

More information

Improved Prediction of Decreased Creatinine Clearance by Serum Cystatin C: Use in Cancer Patients before and during Chemotherapy

Improved Prediction of Decreased Creatinine Clearance by Serum Cystatin C: Use in Cancer Patients before and during Chemotherapy Clinical Chemistry 46:2 193 197 (2000) Enzymes and Protein Markers Improved Prediction of Decreased Creatinine Clearance by Serum Cystatin C: Use in Cancer Patients before and during Chemotherapy Borut

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Non-protein nitrogenous substances (NPN)

Non-protein nitrogenous substances (NPN) Non-protein nitrogenous substances (NPN) A simple, inexpensive screening test a routine urinalysis is often the first test conducted if kidney problems are suspected. A small, randomly collected urine

More information

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

BASELINE CHARACTERISTICS OF THE STUDY POPULATION Study Summary DAILY ORAL SODIUM BICARBONATE PRESERVES GLOMERULAR FILTRATION RATE BY SLOWING ITS DECLINE IN EARLY HYPERTENSIVE NEPHROPATHY This was a 5-year, single-center, prospective, randomized, placebo-controlled,

More information

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007

More information

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

AGING KIDNEY IN HIV DISEASE

AGING KIDNEY IN HIV DISEASE AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV

More information

Chapter 23. Composition and Properties of Urine

Chapter 23. Composition and Properties of Urine Chapter 23 Composition and Properties of Urine Composition and Properties of Urine (1 of 2) urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless

More information

Reducing proteinuria

Reducing proteinuria Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors

More information

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste University of Groningen Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki

More information

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste University of Groningen Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Chronic kidney disease-what can you do and when to refer?

Chronic kidney disease-what can you do and when to refer? Chronic kidney disease-what can you do and when to refer? Dr Goh Heong Keong www.passpaces.com/kidney.htm Outline of Lecture Introduction Epidemiology of CKD in Malaysia/ World Complications of CKD What

More information

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA Management of New-Onset Proteinuria in the Ambulatory Care Setting Akinlolu Ojo, MD, PhD, MBA Urine dipstick results Negative Trace between 15 and 30 mg/dl 1+ between 30 and 100 mg/dl 2+ between 100 and

More information

E.Ritz Heidelberg (Germany)

E.Ritz Heidelberg (Germany) Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow

More information

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel

More information

THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS

THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS 214 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(3):23-212 doi: 1.2478/rjdnmd-214-25 THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES

More information

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme

More information

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Medical parameters Cut-off values BMI (kg/m 2 ) 25.0 Waist (cm) (Men and Women) (Men) 85, (Women) 90

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Outline Introduction of diabetic nephropathy Manifestations of diabetic nephropathy Staging of diabetic nephropathy Microalbuminuria Diagnosis of diabetic nephropathy Treatment of

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates January 2016 By Yunuo (Enora) Wu, PharmD Chronic kidney disease (CKD) is defined as kidney damage (including structural or functional abnormalities) or glomerular filtration rate

More information

Management of early chronic kidney disease

Management of early chronic kidney disease Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown

More information

Update on HIV-Related Kidney Diseases. Agenda

Update on HIV-Related Kidney Diseases. Agenda Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Serra AL, Poster D, Kistler AD, et al. Sirolimus and kidney

More information

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2 Public Health Live T 2 B 2 Chronic Kidney Disease in Diabetes: Early Identification and Intervention Guest Speaker Joseph Vassalotti, MD, FASN Chief Medical Officer National Kidney Foundation Thanks to

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives Evaluation of egfr and mgfr in CKD Use of CKD staging with case scenario Assessment of kidney function in CKD in adults Learning Objectives 台大雲林分院楊淑珍藥師 2017/03/11 Chronic Kidney Disease (CKD) Based on

More information

Primary Care Approach to Management of CKD

Primary Care Approach to Management of CKD Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low

More information

Acute Protein Loading In The Assessment Of Renal Reserve

Acute Protein Loading In The Assessment Of Renal Reserve ORIGINAL ARTICLE Acute Protein Loading In The Assessment Of Renal Reserve C.S. Loo* M. Zaki* A.B. Sulaiman* A.B. Sukanya** Y.c. Voon** S.L. Kua*** * Institute of Urology and Nephrology, * * Department

More information

Assessment of the Effects of the Nitroimidazo-oxazine, PA-824, on Renal Function in Healthy Subjects

Assessment of the Effects of the Nitroimidazo-oxazine, PA-824, on Renal Function in Healthy Subjects AAC Accepts, published online ahead of print on 15 June 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.00112-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease

GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease Nephrol Dial Transplant (2005) 20: 2394 2401 doi:10.1093/ndt/gfi076 Advance Access publication 23 August 2005 Original Article GFR prediction using the MDRD and Cockcroft and Gault equations in patients

More information

Interaction between GFR and Risk Factors for Morbidity and Mortality in African Americans with CKD

Interaction between GFR and Risk Factors for Morbidity and Mortality in African Americans with CKD Article Interaction between GFR and Risk Factors for Morbidity and Mortality in African Americans with CKD Kevin F. Erickson,* Janice Lea, and William M. McClellan Summary Background and objectives The

More information